Unrecognized Tax Benefits in USD of Enliven Therapeutics, Inc. from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Enliven Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2024.
  • Enliven Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2024 was $33.5M, a 4.08% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Enliven Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $33.5M +$1.31M +4.08% Dec 31, 2024 10-K 2025-03-13
Q4 2023 $32.1M +$32M +19500% Dec 31, 2023 10-K 2025-03-13
Q4 2022 $164K +$117K +249% Dec 31, 2022 10-K 2025-03-13
Q4 2021 $47K +$40K +571% Dec 31, 2021 10-K 2024-03-14
Q4 2020 $7K Dec 31, 2020 8-K 2023-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.